Tecan Group AG (CH:TECN)
:TECN
TECN Stock Chart & Stats
CHF131.30
CHF1.00(0.54%)
At close: 4:00 PM EST
CHF131.30
CHF1.00(0.54%)
Day’s Range― - ―
52-Week RangeCHF110.60 - CHF177.50
Previous CloseN/A
Volume42.71K
Average Volume (3M)44.12K
Market Cap
CHF1.68B
Enterprise ValueCHF1.70B
Total Cash (Recent Filing)CHF311.37M
Total Debt (Recent Filing)CHF218.32M
Price to Earnings (P/E)―
Beta1.19
Next Earnings
Aug 19, 2026EPS Estimate
2.9Next Dividend Ex-DateN/A
Dividend Yield2.31%
Share Statistics
EPS (TTM)4.26
Shares Outstanding12,825,883
10 Day Avg. Volume56,389
30 Day Avg. Volume44,118
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)1.41
Price to Sales (P/S)1.84
P/FCF Ratio15.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF163.38Price Target Upside24.43% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)6.03
Revenue Forecast (FY)CHF878.42M
Bulls Say, Bears Say
Bulls Say
Conservative LeverageLow leverage gives Tecan durable financial flexibility to fund R&D, absorb cyclical downturns, and execute capital actions (buybacks or targeted M&A). Even with 2025 equity erosion, a conservative balance sheet supports multi-month resilience and strategic optionality.
Recurring Revenue MixA business model anchored in installed-base consumables, service contracts, software and OEM agreements yields repeatable revenue and steady cash flows. This structural mix reduces sales cyclicality and underpins long-term customer lock-in and predictable aftermarket margin streams.
Order Book And Product InnovationHealthy order intake and recent product introductions paired with cost actions suggest durable demand recovery potential. Sustained book-to-bill >1 and innovation pipeline support medium-term revenue stabilization and margin improvement if execution and supply chain progress continue.
Bears Say
Multi-year Revenue DeclineA multi-year top-line decline signals structural demand, competitive, or product-mix headwinds. Prolonged revenue erosion reduces operating leverage, limits R&D reinvestment, and makes margin recovery harder, increasing the likelihood of sustained earnings weakness absent strategic inflection.
Geographic & Partner ExposureConcentration in China and reliance on OEM/partner volumes expose Tecan to tender delays, inventory destocking, and policy/tariff shifts. These structural external risks can persist, reducing revenue visibility and pressuring margins across planning horizons.
Margin And Cash Momentum DeteriorationSharp margin compression and meaningful FCF decline impair internal funding for innovation and services. Weaker cash conversion limits ability to sustain investments, pay down obligations, or pursue growth, making competitive reinvestment and margin recovery more challenging over months to a few years.
Tecan Group AG News
TECN FAQ
What was Tecan Group AG’s price range in the past 12 months?
Tecan Group AG lowest stock price was CHF110.60 and its highest was CHF177.50 in the past 12 months.
What is Tecan Group AG’s market cap?
Tecan Group AG’s market cap is CHF1.68B.
When is Tecan Group AG’s upcoming earnings report date?
Tecan Group AG’s upcoming earnings report date is Aug 19, 2026 which is in 133 days.
How were Tecan Group AG’s earnings last quarter?
Tecan Group AG released its earnings results on Mar 16, 2026. The company reported CHF4.26 earnings per share for the quarter, beating the consensus estimate of CHF3.39 by CHF0.87.
Is Tecan Group AG overvalued?
According to Wall Street analysts Tecan Group AG’s price is currently Undervalued.
Does Tecan Group AG pay dividends?
Tecan Group AG pays a Annually dividend of CHF3 which represents an annual dividend yield of 2.31%. See more information on Tecan Group AG dividends here
What is Tecan Group AG’s EPS estimate?
Tecan Group AG’s EPS estimate is 2.9.
How many shares outstanding does Tecan Group AG have?
Tecan Group AG has 12,825,883 shares outstanding.
What happened to Tecan Group AG’s price movement after its last earnings report?
Tecan Group AG reported an EPS of CHF4.26 in its last earnings report, beating expectations of CHF3.39. Following the earnings report the stock price went down -3.374%.
Which hedge fund is a major shareholder of Tecan Group AG?
Currently, no hedge funds are holding shares in CH:TECN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tecan Group AG
Tecan Group AG provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and microbodies, and software; Tecan Laberwax, an automation solution; Resolvex, a smart sample preparation solution for use in genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, protein science, applied markets, and ELISA solutions. It also develops and manufactures laboratory instrument manufacturers with essential components comprising precision pumps, valves, robotic arms, and developer software for life science research, diagnostics, and various other industries; Synergence, platform-based automation solution; and Freedom EVO and Fluent instruments. The company operates in Switzerland and Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in Männedorf, Switzerland.
TECN Company Deck
TECN Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture. While Tecan reported strong order entry and growth in the Life Sciences business, challenges in China, a decline in the Partnering Business, and external factors such as tariffs and currency impacts posed significant challenges. The company's strategic initiatives in cost reduction and innovation are positive, but the current market environment remains difficult.View all CH:TECN earnings summariesTECN Stock 12 Month Forecast
Average Price Target
CHF163.38
▲(24.43% Upside)
Technical Analysis
Medacta Group SA
―
Siegfried Holding AG
―
Ypsomed Holding AG
―
SKAN Group AG
―
Medartis Holding AG
―
Options Prices
Currently, No data available
---